Episodes

Latest Episode
Communicable E23: Women & men in medicine: An honest discussion, part 2

Communicable E23: Women & men in medicine: An honest discussion, part 2

S2E23 · · 31:24

Communicable returns to the topic of gender dynamics in medicine in the second half of this special. This round, Angela Huttner wants to hear from the men, CMI Comms editors Marc Bon...

Communicable E22: Women & men in medicine: An honest discussion, part 1

Communicable E22: Women & men in medicine: An honest discussion, part 1

S2E22 · · 40:17

In honour of International Women's Day, Communicable releases the first of a two-part special on gender dynamics within the fields of infectious diseases and clinical microbiology. M...

Communicable E21: FMT for C. difficile infections - does it work?

Communicable E21: FMT for C. difficile infections - does it work?

S2E21 · · 56:32

Several publications have described wondrous therapeutic effects of faecal microbiota transplant (FMT) on Clostridioides difficile infection. Yet the recent randomised trial assessin...

Communicable E20: Tuberculosis today

Communicable E20: Tuberculosis today

S2E20 · · 54:18

Despite being preventable and curable, tuberculosis remains a major global health threat, infecting over 10 million people and claiming more than 1 million lives every year. In this ...

Communicable E19: ‘Super gonorrhoea’ & other sexually transmitted infections

Communicable E19: ‘Super gonorrhoea’ & other sexually transmitted infections

S2E19 · · 58:15

Sexually transmitted infections (STIs) affect millions globally daily, and multidrug-resistant strains are complicating treatment. Hosts Angela Huttner and Josh Davis welcome experts...

Communicable E18: The Nightmare Series, part 4 - How to manage polio and rubella

Communicable E18: The Nightmare Series, part 4 - How to manage polio and rubella

S2E18 · · 59:47

Rising anti-vaccine sentiment and dissemination of misinformation are threats to public health. In the US, calls to revoke certain public health mandates have been proposed by likely...

Communicable E17: Season’s greetings from the editors & holiday replay of late-breaker clinical trials at ESCMID Global 2024

Communicable E17: Season’s greetings from the editors & holiday replay of late-breaker clinical trials at ESCMID Global 2024

S1E17 · · 01:04:39

The last episode of the year carries a special end-of-year message from the CMI Comms editors and replays the very first episode of Communicable aired on 10 May 2024, in which editor...

Communicable E16: Climate change and infections – effects on clinical practice & infection-control efforts

Communicable E16: Climate change and infections – effects on clinical practice & infection-control efforts

S1E16 · · 50:46

The topic of climate change can engender a ‘doom and gloom’ narrative, as many climate and health consequences are already manifesting. Our host, Dr. Navaneeth Narayanan is joined by...

Communicable E15: Wastewater surveillance – can it really protect us from infections?

Communicable E15: Wastewater surveillance – can it really protect us from infections?

S1E15 · · 54:59

Wastewater surveillance is a powerful epidemiological tool that “mirrors our life,” and has gained wide attention in recent years due to its application during the COVID-19 pandemic....

Communicable E14 - Substandard and falsified antimicrobials: what is their effect on patients and on AMR?

Communicable E14 - Substandard and falsified antimicrobials: what is their effect on patients and on AMR?

S1E14 · · 52:00

Substandard and falsified (SF) antimicrobials are a neglected global health problem and have been implicated as drivers of antimicrobial resistance (AMR). Substandard medicines are a...

Communicable E13 - The Wild West of publishing today: predatory journals and how to deal with them

Communicable E13 - The Wild West of publishing today: predatory journals and how to deal with them

S1E13 · · 46:22

The market of predatory publishing is as lucrative as it is unethical. Predatory journals are disguised as legitimate entities, and prey on both early-career academics and the naïve....

Communicable E12 - The Nightmare Series, part 3: How to deal with vancomycin-resistant enterococci

Communicable E12 - The Nightmare Series, part 3: How to deal with vancomycin-resistant enterococci

S1E12 · · 57:01

Enterococci are commensal microbes, part of the healthy microflora populating the human gut. But they are also opportunistic pathogens and notorious nosocomial agents with intrinsic ...

Communicable E11 - Nightmare series, part 2: How to deal with carbapenemase producers

Communicable E11 - Nightmare series, part 2: How to deal with carbapenemase producers

S1E11 · · 01:00:22

Carbapenemase producers are a nightmare for clinicians. Not only are they resistant to carbapenems, a last resort β-lactam antibiotic, they are notorious for developing multidrug and...

Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use

Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use

S1E10 · · 52:37

On the verge of a post-antibiotic reality, there is an urgent clinical need for new antibiotics. Luckily, new candidates are in the pipeline and older agents are getting a second bre...

Communicable E9 - Avian flu: an update

Communicable E9 - Avian flu: an update

S1E9 · · 50:25

The current H5N1 avian flu outbreak in poultry and dairy cows in the US has raised the alarm on bird flu and its transmission risk across species. At present, the virus has infected ...

Communicable E8 - The Nightmare Series, part 1: How to deal with Candida auris

Communicable E8 - The Nightmare Series, part 1: How to deal with Candida auris

S1E8 · · 59:24

Only known to us since 2008, Candida auris is an emerging fungal pathogen spreading quickly around the world; alarmingly, it is most commonly found in healthcare settings. C. auris s...

Communicable E7 - Melioidosis goes global

Communicable E7 - Melioidosis goes global

S1E7 · · 52:08

Once considered endemic only to tropical and subtropical climates such as Southeast Asia and northern Australia, melioidosis is expanding to non-endemic areas such as the southern US...

Communicable E6 - “Sneaky viruses”: an update on hepatitis B & C before World Hepatitis Day

Communicable E6 - “Sneaky viruses”: an update on hepatitis B & C before World Hepatitis Day

S1E6 · · 54:06

Responsible for 1.3 million deaths and 2.2 million new infections per year, viral hepatitis is the second leading cause of morbidity and mortality amongst all infectious diseases, ju...

Communicable E5 - Beauty is in the 'I' of the beholder: EUCAST updates

Communicable E5 - Beauty is in the 'I' of the beholder: EUCAST updates

S1E5 · · 38:31

The ‘I’ (intermediate susceptibility) in a EUCAST-guided antibiogram never meant impending resistance to your antibiotic. It was never meant to make you find the one ‘S’ (invariably ...

Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice?

Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice?

S1E4 · · 44:52

Hosts Angela Huttner & Erin McCreary welcome Prof. David Paterson (Singapore) and Prof. Josh Davis (Newcastle, Australia) to discuss the design and results of the BLING-3 trial, whic...

Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first?

Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first?

S1E3 · · 42:58

What are WHO's most wanted bacterial pathogens in 2024? Hosts Angela Huttner & Oana Sandulescu welcome guests Dr. Hatim Sati of the World Health Organisation (WHO) and Dr. Erin Duffy...

Communicable E2 - Phage therapy: does it work and will we have access?

Communicable E2 - Phage therapy: does it work and will we have access?

S1E2 · · 54:00

In this episode, hosts Josh Davis (Newcastle, Australia) and Angela Huttner (Geneva, Switzerland) interview the phage ‘microbiologist-clinician duo’, Drs. Shawna McCallin and Lorenz ...

Communicable E1 - Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice?

Communicable E1 - Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice?

S1E1 · · 58:02

CMI Communications editors Angela Huttner, Marc Bonten, and Erin McCreary discuss late-breaker clinical trials presented at ESCMID Global (ECCMID) in Barcelona, providing insights in...